Advertisement
DIA
Drug Information Association Logo

Meetings & Training

DIA’s comprehensive educational portfolio reflects and advances innovation in the pharmaceutical, biotechnology, medical device, and related fields and facilitates open dialogue among key professionals from industry, government, academia, and patient organizations.

Find Meetings & Training 

Name Start Date Credits Format Region Location
Expert Reactor Panel: IOM Report on Sharing Clinical Trial Data Apr 26, 2015 Online Instruction Global Online
Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Apr 26, 2015 Online Instruction Global Online
Generic Drug Labeling Proposed Rule and Safety Updates Apr 26, 2015 Online Instruction Global Online
FDA’s Evolving Position on the Brief Summary and Adequate Directions for Use Guidance Apr 26, 2015 Online Instruction Global Online
Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Apr 26, 2015 Online Instruction Global Online
GVP Module IX Compliant Signal Management Systems in Pharmacovigilance: A Tale of Two Experiences Apr 26, 2015 Online Instruction Global Online
Complimentary Webinar - Using Revolutionary Machine Learning to Find the Most Relevant Content to Drive Informed Decisions in Regulatory Intelligence Apr 26, 2015 Online Instruction Global Online
The Role of the Clinical Data Manager Apr 26, 2015 Online Instruction Global Online
Implementation of the FDASIA Patient Provisions Apr 26, 2015 Online Instruction Global Online
Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Apr 26, 2015 Online Instruction Global Online
Variations in the European Union: CMC/Quality Changes Apr 26, 2015 Online Instruction Global Online
Proarrhythmia Apr 26, 2015 Online Instruction Global Online
Facets of Drug-Induced Kidney Injury and Regulatory Perspective Apr 26, 2015 Online Instruction Global Online
Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Apr 26, 2015 Online Instruction Global Online
Pharmacovigilance and Risk Management: Patient Perspective Apr 26, 2015 Online Instruction Global Online
Drug Safety Regulatory Requirements Apr 26, 2015 ACPE, IACET Online Instruction Global Online
Premarketing Clinical Trial Safety Apr 26, 2015 ACPE, IACET Online Instruction Global Online
Postmarketing Safety Management Apr 26, 2015 ACPE, IACET Online Instruction Global Online
Basics of Signal Detection and Pharmacoepidemiology Apr 26, 2015 ACPE, IACET Online Instruction Global Online
Safety Audits and Inspections Apr 26, 2015 ACPE, IACET Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Apr 26, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Apr 26, 2015 Online Instruction Global Online
Pharmacovigilance and Global Harmonization Updates Apr 26, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Apr 26, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Apr 26, 2015 Online Instruction Global Online
Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Apr 26, 2015 Online Instruction Global Online
Designed for Success: Utilizing Protocol Quality by Design (QbD) to Plan Clinical Studies Apr 26, 2015 Online Instruction Global Online
Negotiation and Influence Apr 26, 2015 Online Instruction Global Online
Introduction to Drug Safety Apr 26, 2015 ACPE, IACET Online Instruction Global Online
How to Prepare for a Safety Inspection Apr 26, 2015 Online Instruction Global Online
Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Apr 26, 2015 Online Instruction Global Online
Clinical Statistics for Nonstatisticians Apr 26, 2015 Online Instruction Global Online
Advanced Clinical Statistics for Nonstatisticians Apr 26, 2015 Online Instruction Global Online
Development of a Clinical Study Report Apr 26, 2015 Online Instruction Global Online
Art of Writing a Clinical Overview Apr 26, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Apr 26, 2015 Online Instruction Global Online
Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Apr 26, 2015 Online Instruction Global Online
Complimentary Webinar - How to Cut Clinical Trial Timelines in Half Apr 26, 2015 Online Instruction Global Online
Disruptive Innovation in Medical Information Apr 26, 2015 Online Instruction Global Online
A Tour of FDA Apr 26, 2015 Online Instruction Global Online
A Tour of Health Canada Apr 26, 2015 Online Instruction Global Online
A Tour of Health Europe Apr 26, 2015 Online Instruction Global Online
Aspects of Regulatory History Apr 26, 2015 Online Instruction Global Online
Bioresearch Monitoring Program (BIMO): Introduction Apr 26, 2015 Online Instruction Global Online
The Clinical Development Process: Investigational Product, Plan, and Data Management Apr 26, 2015 Online Instruction Global Online
Ethical Review Boards Apr 26, 2015 Online Instruction Global Online
Ethics as the Foundation to Clinical Research Apr 26, 2015 Online Instruction Global Online
Awareness of FDA Inspections for Pharmaceutical Manufacturers Apr 26, 2015 Online Instruction Global Online
Biotechnology: An Overview of Compliance Considerations Apr 26, 2015 Online Instruction Global Online
Change Control Apr 26, 2015 Online Instruction Global Online
Clinical Trial Audits and Consequences of Non-Compliance Apr 26, 2015 Online Instruction Global Online
Computerized Systems Inspections in the Medical Device Industry Apr 26, 2015 Online Instruction Global Online
European Union Clinical Trials Directive Apr 26, 2015 Online Instruction Global Online
GMP Principals of SOPs Apr 26, 2015 Online Instruction Global Online
GMP Updates - Enforcement Changes at the New FDA Apr 26, 2015 Online Instruction Global Online
GMPs for API Bulk Manufacturers Apr 26, 2015 Online Instruction Global Online
Good Clinical Practices (GCPs) for New Product Investigations Apr 26, 2015 Online Instruction Global Online
Good Laboratory Practices (GLPs) Apr 26, 2015 Online Instruction Global Online
GxPs Apr 26, 2015 Online Instruction Global Online
HIPAA - The Impact on Clinical Research Apr 26, 2015 Online Instruction Global Online
Introduction to GMPs Apr 26, 2015 Online Instruction Global Online
Investigational Product Development Apr 26, 2015 Online Instruction Global Online
ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Apr 26, 2015 Online Instruction Global Online
Key Concepts of Process Validation Apr 26, 2015 Online Instruction Global Online
Laboratory Specimens for Clinical Research Apr 26, 2015 Online Instruction Global Online
Medical Device Safety Reporting Apr 26, 2015 Online Instruction Global Online
Orientation to GMP Compliance Apr 26, 2015 Online Instruction Global Online
Overview of the Clinical Research Process Apr 26, 2015 Online Instruction Global Online
Part 11: Electronic Records and Signatures - Application Apr 26, 2015 Online Instruction Global Online
Part 11: Electronic Records; Electronic Signatures Apr 26, 2015 Online Instruction Global Online
Principles of Good Documentation Apr 26, 2015 Online Instruction Global Online
Protection of Human Subjects in Clinical Trials Apr 26, 2015 Online Instruction Global Online
Selecting and Managing Clinical Contract Research Organizations (CROs) Apr 26, 2015 Online Instruction Global Online
Understanding Post-Approval Changes Apr 26, 2015 Online Instruction Global Online
Computerized Systems Inspections in the Pharmaceutical Industry Apr 26, 2015 Online Instruction Global Online
Basics of the PhRMA Code Apr 26, 2015 Online Instruction Global Online
Basics of AdvaMed Code Apr 26, 2015 Online Instruction Global Online
Eucomed Guidelines on Interactions with Healthcare Professionals Apr 26, 2015 Online Instruction Global Online
Introduction to Medical Device Health Care Compliance Apr 26, 2015 Online Instruction Global Online
Foreign Corrupt Practices Act Apr 26, 2015 Online Instruction Global Online
Global Anti-bribery Apr 26, 2015 Online Instruction Global Online
Variations to Marketing Authorisation in Europe Apr 26, 2015 Online Instruction Global Online
Registration of Monoclonal Antibodies Apr 26, 2015 Online Instruction Global Online
How to Gain Approval to Market a Generic Medicinal Product in the USA Apr 26, 2015 Online Instruction Global Online
Pharmacokinetics and Pharmacodynamics in Drug Registration Apr 26, 2015 Online Instruction Global Online
Implementing Risk-Based Monitoring: Practical Approaches Apr 26, 2015 Online Instruction Global Online
Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Apr 26, 2015 Online Instruction Global Online
Complimentary - Risk-Based Monitoring: Regulatory Expectation and Operational Application Apr 26, 2015 Online Instruction Global Online
Fundamentals of Project Management for Nonproject Managers Apr 26, 2015 Online Instruction Global Online
Planning and Managing Your Projects Apr 26, 2015 Online Instruction Global Online
Team Building and Development Apr 26, 2015 Online Instruction Global Online
Preparing a Clinical Trial Budget Apr 26, 2015 Online Instruction Global Online
Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations and Challenges to Overcome Apr 26, 2015 Online Instruction Global Online
Introduction to the European Union Institutions and Regulatory Authority Apr 26, 2015 Online Instruction Global Online
Introduction to US Institutions and Regulatory Authority (FDA) Apr 26, 2015 Online Instruction Global Online
Introduction to Japanese Institutions and Regulatory Authorities Apr 26, 2015 Online Instruction Global Online
Overview of the CTD and eCTD Apr 26, 2015 Online Instruction Global Online
Introduction to the International Conference on Harmonisation (ICH) Apr 26, 2015 Online Instruction Global Online
The Regulatory Development of a Drug Apr 26, 2015 Online Instruction Global Online
Basics of Clinical Trials Apr 26, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Centralized Procedure Apr 26, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Mutual Recognition Procedure Apr 26, 2015 Online Instruction Global Online
How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Apr 26, 2015 Online Instruction Global Online
How to Register a New Drug in the USA Apr 26, 2015 Online Instruction Global Online
How to Register Medicinal Products through the Decentralized Procedure Apr 26, 2015 Online Instruction Global Online
Access to Unapproved Drugs through Compassionate Use Apr 26, 2015 Online Instruction Global Online
Regulatory Requirements for the Conduct of Clinical Trials in Europe Apr 26, 2015 Online Instruction Global Online
Orphan Drugs in the USA, European Union, and Japan Apr 26, 2015 Online Instruction Global Online
Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Apr 26, 2015 Online Instruction Global Online
Meeting Opportunities with Regulatory Agencies Apr 26, 2015 Online Instruction Global Online
Complementary - How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Apr 26, 2015 Online Instruction Global Online
Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Apr 26, 2015 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Apr 26, 2015 Online Instruction Global Online
Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Apr 26, 2015 Online Instruction Global Online
Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Apr 26, 2015 Online Instruction Global Online
Adverse Event Reporting Requirements: IND and Postmarketing Apr 26, 2015 Online Instruction Global Online
Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Apr 26, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Apr 26, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Apr 26, 2015 Online Instruction Global Online
Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Apr 26, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Apr 26, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Apr 26, 2015 Online Instruction Global Online
Basics of the IND Apr 26, 2015 Online Instruction Global Online
Basics of the NDA Apr 26, 2015 Online Instruction Global Online
Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Apr 26, 2015 Online Instruction Global Online
Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Apr 26, 2015 Online Instruction Global Online
Supplements and Other Changes to an Approved Application Apr 26, 2015 Online Instruction Global Online
Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Apr 26, 2015 Online Instruction Global Online
Key Considerations for Biosimilar R&D Workshop Apr 27, 2015 Meetings China
FDA’s Evolving Position on the Brief Summary and Adequate Directions for Use Guidance Apr 28, 2015 IACET Online Instruction Global Online
Basics of the IND Phase May 4, 2015 IACET Online Instruction Global Online
Oversight of Clinical Monitoring: Trends and Strategies May 5, 2015 IACET Online Instruction Global Online
eRegulatory and Intelligence Virtual Conference May 11, 2015 Meetings Global
Complimentary Webinar - Next Generation Feasibility: Better Planning Through Simulation May 13, 2015 Online Instruction Global Online
Basics of the NDA Phase May 18, 2015 IACET Online Instruction Global Online
Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations and Challenges to Overcome May 19, 2015 ACPE, IACET Online Instruction Global Online
The 7th DIA China Annual Meeting May 24, 2015 Meetings China Shanghai, China
How to Prepare for a Safety Inspection Jun 1, 2015 IACET Online Instruction Global Online
Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 IACET Online Instruction Global Online
Interactions with the FDA during IND/NDA Phases Jul 16, 2015 Online Instruction Global Online
Overview of Drug Development in Japan Sep 2, 2015 Online Instruction Global Online
Introduction to Signal Detection and Data Mining Oct 5, 2015 IACET Online Instruction Global Online
The 1st DIA China Drug Discovery Innovation Conference & Exhibition Oct 11, 2015 Meetings China Shanghai, China